1322 related articles for article (PubMed ID: 28058848)
21. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
22. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
Kutyifa V; Beck C; Brown MW; Cannom D; Daubert J; Estes M; Greenberg H; Goldenberg I; Hammes S; Huang D; Klein H; Knops R; Kosiborod M; Poole J; Schuger C; Singh JP; Solomon S; Wilber D; Zareba W; Moss AJ;
Am Heart J; 2017 Jul; 189():158-166. PubMed ID: 28625372
[TBL] [Abstract][Full Text] [Related]
23. Early ICD implantation in cardiac arrest survivors with acute coronary syndrome - predictors of implantation, ICD-therapy and long-term survival.
Søholm H; Laursen ML; Kjaergaard J; Lindhardt TB; Hassager C; Møller JE; Gregers E; Linde L; Johansen JB; Winther-Jensen M; Lippert FK; Køber L; Philbert BT
Scand Cardiovasc J; 2021 Aug; 55(4):205-212. PubMed ID: 33749460
[No Abstract] [Full Text] [Related]
24. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
[TBL] [Abstract][Full Text] [Related]
25. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
[TBL] [Abstract][Full Text] [Related]
26. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
27. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
[TBL] [Abstract][Full Text] [Related]
28. Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: Insight from the national inpatient sample.
Munir MB; Alqahtani F; Aljohani S; Bhirud A; Modi S; Alkhouli M
Pacing Clin Electrophysiol; 2018 Mar; 41(3):229-237. PubMed ID: 29318626
[TBL] [Abstract][Full Text] [Related]
29. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
30. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
[TBL] [Abstract][Full Text] [Related]
31. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
[TBL] [Abstract][Full Text] [Related]
32. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
33. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006).
Scott PA; Gorman S; Andrews NP; Roberts PR; Kalra PR
Europace; 2008 Apr; 10(4):453-7. PubMed ID: 18319266
[TBL] [Abstract][Full Text] [Related]
34. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
36. CPR Induced Inappropriate Shocks from a Subcutaneous Implantable Cardioverter Defibrillator during Out-of-Hospital Cardiac Arrest.
Cmorej P; Smrzova E; Peran D; Bulikova T
Prehosp Emerg Care; 2020; 24(1):85-89. PubMed ID: 30905240
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Implications of Level-of-Care at Tertiary Heart Centers Compared With Other Hospitals After Resuscitation From Out-of-Hospital Cardiac Arrest.
Søholm H; Kjaergaard J; Bro-Jeppesen J; Hartvig-Thomsen J; Lippert F; Køber L; Nielsen N; Engsig M; Steensen M; Wanscher M; Karlsen FM; Hassager C
Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):268-76. PubMed ID: 25944632
[TBL] [Abstract][Full Text] [Related]
39. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
[TBL] [Abstract][Full Text] [Related]
40. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
